ÒÎÐ 5 ñòàòåé: Ìåòîäè÷åñêèå ïîäõîäû ê àíàëèçó ôèíàíñîâîãî ñîñòîÿíèÿ ïðåäïðèÿòèÿ Ïðîáëåìà ïåðèîäèçàöèè ðóññêîé ëèòåðàòóðû ÕÕ âåêà. Êðàòêàÿ õàðàêòåðèñòèêà âòîðîé ïîëîâèíû ÕÕ âåêà Õàðàêòåðèñòèêà øëèôîâàëüíûõ êðóãîâ è åå ìàðêèðîâêà Ñëóæåáíûå ÷àñòè ðå÷è. Ïðåäëîã. Ñîþç. ×àñòèöû ÊÀÒÅÃÎÐÈÈ:
|
Õ³ðóðã³÷íå âòðó÷àííÿ ó ïàö³ºíò³â, ÿê³ ïðîõîäÿòü àíòèòðîìáîöèòàðíó òåðàï³þ 2 ñòðàíèöà42. Long J, Luckraz H, Thekkudan J, Maher A, Norell M. Heart Team discussion in managingpatients with coronary artery disease: outcome and reproducibility. InteractCardiovasc Thorac Surg 2012;14(5):594–598 43. Sobolev BG, Fradet G, Kuramoto L, Rogula B. The occurrence of adverse events inrelation to time after registration for coronary artery bypass surgery: a populationbasedobservational study. J Cardiothorac Surg 2013;8:74 44. Graham MM, Knudtson ML, O’Neill BJ, Ross DB. Treating the right patient at theright time: Access to cardiac catheterization, percutaneous coronary interventionand cardiac surgery. Can J Cardiol 2006;22(8):679–683 45. Hannan EL, Samadashvili Z, Walford G, Holmes DR, Jacobs A, Sharma S, Katz S,King SB 3rd. Predictors and outcomes of ad hoc vs. non-ad hoc percutaneous coronaryinterventions. JACC Cardiovasc Interv 2009;2(4):350–356 46. Nallamothu BK, Krumholz HM. Putting ad hoc PCI on pause. JAMA 2010;304(18):2059–2060 47. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A,Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK,Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R,Taggart DP, van der Wall EE, Vrints CJ, Zamorano JL, Baumgartner H, Bax JJ,Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW,Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P,Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A,Wijns W, Windecker S, Valgimigli M, Claeys MJ, Donner-Banzhoff N, Frank H,Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Husted S,James SK, Kervinen K, Kristensen SD, Maggioni AP, Pries AR, Romeo F, Ryden L,Simoons ML, Steg PG, Timmis A, Yildirir A. 2013 ESC guidelines on the managementof stable coronary artery disease: The Task Force on the management ofstable coronary artery disease of the European Society of Cardiology. Eur Heart J2013;34(38):2949–3003 48. Knuuti J, Bengel F, Bax JJ, Kaufmann PA, Le Guludec D, Perrone Filardi P, Marcassa C,Ajmone Marsan N, Achenbach S, Kitsiou A, Flotats A, Eeckhout E, Minn H, Hesse BRisks and benefits of cardiac imaging: an analysis of risks related to imaging for coronaryartery disease. Eur Heart J 2014;35(10):633–638 48a. Amsterdam EA, Kirk JD, Bluemke DA, Diercks D, Farkouh ME, Garvey JL, Kontos MC, McCord J, Miller TD, Morise A, Newby LK, Ruberg FL, Scordo KA, Thompson PD. Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. Circulation 2010;122:1756–1776. 49. Hulten E, Villines TC, Cheezum MK, Berman DS, Dunning A, Achenbach S,Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY,Chinnaiyan K, Chow BJ, Cury RC, Delago A, Feuchtner G, Hadamitzky M,Hausleiter J, Kaufmann PA, Karlsberg RP, Kim YJ, Leipsic J, Lin FY, Maffei E,Plank F, Raff GL, Labounty TM, Shaw LJ, Min JK, Investigators C. Usefulness of coronarycomputed tomography angiography to predict mortality and myocardial infarctionamong Caucasian, African and East Asian ethnicities (from the CONFIRM[Coronary CT Angiography Evaluation for Clinical Outcomes: An InternationalMulticenter] Registry). Am J Cardiol 2013;111(4):479–485 50. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t Veer M, Klauss V,Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA,Fearon WF, Investigators FS. Fractional flow reserve vs. angiography for guidingpercutaneous coronary intervention. N Engl J Med 2009;360(3):213–224 50a. Diamond GA.Aclinically relevant classification of chest discomfort. JAmColl Cardiol 1983;1:574–575. 51. Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van’t Veer M,Bar F, Hoorntje J, Koolen J, WijnsW, de Bruyne B. Percutaneous coronary interventionof functionally nonsignificant stenosis: 5-year follow-up of the DEFER StudyJ Am Coll Cardiol 2007;49(21):2105–2111 51a. Lanza GA, Sestito A, Sgueglia GA, Infusino F, Manolfi M, Crea F, Maseri A. Current clinical features, diagnostic assessment and prognostic determinants of patients with variant angina. Int J Cardiol 2007;118:41–47. 52. Botman KJ, Pijls NH, Bech JW, Aarnoudse W, Peels K, van Straten B, Penn O,Michels HR, Bonnier H, Koolen JJ. Percutaneous coronary intervention or bypasssurgery in multivessel disease? A tailored approach based on coronary pressuremeasurement. Catheter Cardiovasc Interv 2004;63(2):184–191 53. Toth G,DeBruyne B, Casselman F,DeVroey F, Pyxaras S, Di Serafino L, Van Praet F,Van Mieghem C, Stockman B, Wijns W, Degrieck I, Barbato E. Fractional flowreserve-guided vs. angiography-guided coronary artery bypass graft surgery. Circulation2013;128(13):1405–1411 54. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N,Mobius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T,Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N,Johnson JB, Juni P, Fearon WF, Investigators FT. Fractional flow reserve-guidedPCI vs. medical therapy in stable coronary disease. N Engl J Med 2012;367(11):991–1001 55. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing andimpact of revascularization on prognosis in patients with coronary artery diseaseand left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39(7):1151–1158 56. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY,Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A, Iwanochko RM, InvestigatorsP-. F-18-fluorodeoxyglucose positron emission tomographyimaging-assisted management of patients with severe left ventricular dysfunctionand suspected coronary disease: a randomized, controlled trial (PARR-2). J AmColl Cardiol 2007;50(20):2002–2012 56a. Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Tex Heart Inst J 2013;40: 17–29. . 57. Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA,Nieman K, van Werkhoven JM, Pundziute G, Weustink AC, de Vos AM,Pugliese F, Rensing B, Jukema JW, Bax JJ, Prokop M, Doevendans PA, Hunink MG,Krestin GP, de Feyter PJ. Diagnostic accuracy of 64-slice computed tomographycoronary angiography: a prospective, multicenter, multivendor study. J Am CollCardiol 2008;52(25):2135–2144 57a. Ryden L. ESC Guideline diabetes 2013. Eur Heart J 2013 58. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N,Clouse ME, Shapiro EP, Hoe J, Lardo AC, Bush DE, de Roos A, Cox C, Brinker J,Lima JA. Diagnostic performance of coronary angiography by 64-row CT. N EnglJ Med 2008;359(22):2324–2336 59. Sarno G, Decraemer I, Vanhoenacker PK, De Bruyne B, Hamilos M, Cuisset T,Wyffels E, Bartunek J, Heyndrickx GR, WijnsW. On the inappropriateness of noninvasivemultidetector computed tomography coronary angiography to triggercoronary revascularization: a comparison with invasive angiography. JACC CardiovascInterv 2009;2(6):550–557 60. Schuijf JD, WijnsW, Jukema JW, Decramer I, Atsma DE, de Roos A, Stokkel MP,Dibbets-Schneider P, van der Wall EE, Bax JJ. A comparative regional analysis ofcoronary atherosclerosis and calcium score on multislice CT vs. myocardial perfusionon SPECT. J Nucl Med 2006;47(11):1749–55 61. Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M,Bellinger R, Martin A, Benton R, Delago A, Min JK. Diagnostic performance of64-multidetector row coronary computed tomographic angiography for evaluationof coronary artery stenosis in individuals without known coronary arterydisease: results from the prospective multicenter ACCURACY (Assessment byCoronary Computed Tomographic Angiography of Individuals Undergoing InvasiveCoronary Angiography) trial. J Am Coll Cardiol 2008;52(21):1724–1732 62. Neglia D, Rovai D, Caselli C, Kaufmann P, Lombardi M, Lorenzoni V, Marinelli M,Nekolla D, Pietila M, Scholte A, Sicari R, Teresinska A, Zamorano J,Underwood R, Knuuti J, For the EVINCI Investigators. Detection of obstructivecoronary artery disease by non invasive anatomical and functional imaging Results of the multicenter European EVINCI study. Circulation 2013 62a. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769–1818. 63. Elhendy A, Shub C, McCully RB, Mahoney DW, Burger KN, Pellikka PA. Exerciseechocardiography for the prognostic stratification of patients with low pretestprobability of coronary artery disease. Am J Med 2001;111(1):18–23 63a. Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, O’Rourke RA, Boden WE, Weintraub WS. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol 2009;104:1647–1653. 64. Elhendy A, MahoneyDW, Burger KN, McCully RB, Pellikka PA. Prognostic value ofexercise echocardiography in patients with classic angina pectoris. Am J Cardiol2004;94(5):559–563 64a. Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, Smith MS, Califf RM, Mark DB, OwenWFJr. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. JAmSoc Nephrol 2003;14:2373–2380. 65. Sicari R, Pasanisi E, Venneri L, Landi P, Cortigiani L, Picano E, Echo Persantine InternationalCooperative Study G, Echo Dobutamine International CooperativeStudy G. Stress echo results predict mortality: a large-scale multicenter prospectiveinternational study. J Am Coll Cardiol 2003;41(4):589–595 65a. Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 2010;341:c4986 66. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, Borges-Neto S,Berman DS, Waters DD, Heller GV. Impact of diabetes on the risk stratificationusing stress single-photon emission computed tomography myocardial perfusionimaging in patients with symptoms suggestive of coronary artery disease. Circulation2002;105(1):32–40 66a. CockcroftDW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41. 67. Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Doesrubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosisof obstructive coronary disease?: A systematic reviewand meta-analysis. J AmColl Cardiol 2012;60(18):1828–1837 68. ShawLJ,Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, Krawczynska E,Cerqueira M, Maddahi J, Myoview Multicenter R. Prognostic value of normal exerciseand adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenterregistry of 4,728 patients. J Nucl Med 2003;44(2):134–139 69. Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR,Hertenstein GK, Moutray KL, Reid K, Cullom SJ. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gatedTc-99m sestamibi SPECT. J Nucl Cardiol 2006;13(1):24–33 70. Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, Calamari B,Coleman CI, Heller GV. Diagnostic accuracy of cardiac positron emission tomographyvs. single photon emission computed tomography for coronary arterydisease: a bivariate meta-analysis. Circ Cardiovasc Imaging 2012;5(6):700–707 71. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnosticperformance of stress cardiac magnetic resonance imaging in the detection of coronaryartery disease: a meta-analysis. J Am Coll Cardiol 2007;50(14):1343–1353 72. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H,Dill T, Larsson HB, Flamm SD, Marquardt M, Johansson L. MR-IMPACT: comparisonof perfusion-cardiac magnetic resonance with single-photon emission computedtomography for the detection of coronary artery disease in a multicentre,multivendor, randomized trial. Eur Heart J 2008;29(4):480–489 73. Schwitter J,Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schonberg SO,Luchner A, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T, Investigators M-IMR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessmentin Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. singlephotonemission computed tomography for the detection of coronary arterydisease: a comparative multicentre, multivendor trial. Eur Heart J 2013;34(10):775–781 74. Jahnke C, Nagel E, Gebker R, KokocinskiT, Kelle S, Manka R, Fleck E, Paetsch I. Prognosticvalue of cardiac magnetic resonance stress tests: adenosine stress perfusionand dobutamine stress wall motion imaging. Circulation 2007;115(13):1769–1776 75. Korosoglou G, Elhmidi Y, Steen H, Schellberg D, Riedle N, Ahrens J, Lehrke S,Merten C, Lossnitzer D, Radeleff J, Zugck C, Giannitsis E, Katus HA. Prognosticvalue of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutivepatients: assessment of myocardial wall motion and perfusion. J Am CollCardiol 2010;56(15):1225–1234 76. Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E,Chow BJ, Min JK, Pencina MJ, Berman DS, Shaw LJ. Prognostic value of stress myocardialperfusion positron emission tomography: results from a multicenter observationalregistry. J Am Coll Cardiol 2013;61(2):176–184 77. Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, Dorbala S, Blankstein R,Di Carli MF. Association between coronary vascular dysfunction and cardiacmortality in patients with and without diabetes mellitus. Circulation 2012;126(15):1858–1868 78. Kajander S, Joutsiniemi E, Saraste M, Pietila M, Ukkonen H, Saraste A, Sipila HT,Teras M, Maki M, Airaksinen J, Hartiala J, Knuuti J. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionallysignificant coronary artery disease. Circulation 2010;122(6):603–613 78a. Androulakis A, Aznaouridis KA, Aggeli CJ, Roussakis GN, Michaelides AP, Kartalis AN, Stougiannos PN, Dilaveris PE, Misovoulos PI, Stefanadis CI, Kallikazaros IE. Transient ST-segment depression during paroxysms of atrial fibrillation in otherwise normal individuals: relation with underlying coronary artery disease. J Am Coll Cardiol 2007;50:1909–1911. 79. Pazhenkottil AP, Nkoulou RN, Ghadri JR, Herzog BA, Kuest SM, Husmann L,Wolfrum M, Goetti R, Buechel RR, Gaemperli O, Luscher TF, Kaufmann PAImpact of cardiac hybrid single-photon emission computed tomography/computedtomography imaging on choice of treatment strategy in coronary artery disease. EurHeart J 2011;32(22):2824–2829 80. Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, van den Oever ML,Heymans MW, Tulevski II, van Kuijk C, Hoekstra OS, Lammertsma AA,Lubberink M, van Rossum AC, Knaapen P. Hybrid imaging using quantitativeH215O PET and CT-based coronary angiography for the detection of coronaryartery disease. J Nucl Med 2013;54(1):55–63 80a. Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, Picard MH, Polk DM, Ragosta M,Ward RP,Weiner RB. ACCF/ASE/AHA/ASNC/HFSA/HRS/ SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. AReport of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society forCardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. J Am Coll Cardiol 2011;57:1126–1166. 81. Schaap J, de Groot JA, Nieman K, Meijboom WB, Boekholdt SM, Post MC, Van derHeyden JA, de Kroon TL, Rensing BJ, Moons KG, Verzijlbergen JF. Hybrid myocardialperfusion SPECT/CT coronary angiography and invasive coronary angiographyin patients with stable angina pectoris lead to similar treatment decisions. Heart2013;99(3):188–194 82. Fiechter M, Ghadri JR, Wolfrum M, Kuest SM, Pazhenkottil AP, Nkoulou RN,Herzog BA, Gebhard C, Fuchs TA, Gaemperli O, Kaufmann PA. Downstream resourceutilization following hybrid cardiac imaging with an integratedcadmium-zinc-telluride/64-slice CT device. Eur J Nucl Med Mol Imaging 2012;39(3):430–436 83. van Werkhoven JM, Heijenbrok MW, Schuijf JD, Jukema JW, van der Wall EE,Schreur JH, Bax JJ. Combined non-invasive anatomical and functional assessmentwith MSCT and MRI for the detection of significant coronary artery disease inpatients with an intermediate pre-test likelihood. Heart 2010;96(6):425–431 84. Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C,Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J,Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J,Valensi P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V,Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P,Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA,Tamargo JL, Torbicki A, Wijns W, Windecker S, De Backer G, Ezquerra EA,Avogaro A, Badimon L, Baranova E, Betteridge J, Ceriello A, Funck-Brentano C,Gulba DC, Kjekshus JK, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Reiner Z,Sattar N, Schachinger V, Scheen A, Schirmer H, Stromberg A, Sudzhaeva S,Viigimaa M, Vlachopoulos C, Xuereb RG. ESC Guidelines on diabetes, prediabetes,and cardiovascular diseases developed in collaboration with the EASD:the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the EuropeanSociety of Cardiology (ESC) and developed in collaboration with the EuropeanAssociation for the Study of Diabetes (EASD). Eur Heart J 2013;34(39):3035–3087 85. Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K,James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF,Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW,Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularizationEur J Cardiothorac Surg 2010;38 Suppl:S1–S52 86. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K,James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF,Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW,Silber S, Sousa Uva M, Taggart D, Vahanian A, Auricchio A, Bax J, Ceconi C,Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T,Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE,Widimsky P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G,Vouhe P, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ,Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J,Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA,Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y,SabateM, Starc R, Thielmann M, Wheatley DJ,Windecker S, Zembala M. Guidelineson myocardial revascularization: The Task Force on Myocardial Revascularizationof the European Society of Cardiology (ESC) and the European Association forCardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31(20):2501–2555 87. Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE. Coronary arterybypass graft surgery vs.percutaneous interventions in coronary revascularization:a systematic review. JAMA 2013;310(19):2086–2095 88. Spertus JA, Salisbury AC, Jones PG, Conaway DG, Thompson RC. Predictors ofquality-of-life benefit after percutaneous coronary intervention. Circulation 2004;110(25):3789–3794 88a. Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation 2003;108: 263–1277. 89. Coronary angioplasty vs. medical therapy for angina: the second Randomised InterventionTreatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet 1997;350(9076):461–468 90. Trial of invasive vs. medical therapy in elderly patients with chronic symptomaticcoronary-artery disease (TIME): a randomised trial. Lancet 2001;358(9286):951–957 90a. Diamond GA,Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Eng J Med 1979;300:1350–1358. 91. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ,Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L,Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER,Spertus JA, Berman DS, Mancini GB, Weintraub WS, Group CTR. Optimalmedical therapy with or without PCI for stable coronary disease. N Engl J Med2007;356(15):1503–1516 92. Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT,Dubach P, Resink TJ, Pfisterer M. Effects of percutaneous coronary interventionsin silent ischemia after myocardial infarction: the SWISSI II randomized controlledtrial. JAMA 2007;297(18):1985–1991 93. Frye RL, August P, BrooksMM,Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ,Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME,NestoRW, Sako EY, Sobel BE. A randomized trial of therapies for type 2 diabetesand coronary artery disease. N Engl J Med 2009;360(24):2503–2515 94. Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D,Rocha AS, Hueb AC, Ramires JA. Ten-year follow-up survival of the Medicine,Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of3 therapeutic strategies for multivessel coronary artery disease. Circulation 2010;122(10):949–957 95. Wijeysundera HC, Nallamothu BK, Krumholz HM, Tu JV, Ko DT. Meta-analysis:effects of percutaneous coronary intervention vs. medical therapy on anginarelief. Ann Intern Med 2010;152(6):370–379 96. Pursnani S, Korley F, Gopaul R, Kanade P, Chandra N, Shaw RE, Bangalore S. Percutaneouscoronary intervention vs. optimal medical therapy in stable coronaryartery disease: a systematic review and meta-analysis of randomized clinical trials Circ Cardiovasc Interv 2012;5(4):476–490 97. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD,Hayes SW, Cohen I, Germano G, Berman DS. Impact of ischaemia and scar onthe therapeutic benefit derived from myocardial revascularization vs. medicaltherapy among patients undergoing stress-rest myocardial perfusion scintigraphy Eur Heart J 2011;32(8):1012–1024 98. Sajadieh A, NielsenOW, Rasmussen V, Hein HO, Hansen JF. Prevalence and prognosticsignificance of daily-life silent myocardial ischaemia in middle-aged andelderly subjects with no apparent heart disease. Eur Heart J 2005;26(14):1402–1409 99. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM,Weintraub WS, O’Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J,Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ,Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK,Boden WE, Investigators C. Optimal medical therapy with or without percutaneouscoronary intervention to reduce ischemic burden: results from the ClinicalOutcomes Utilizing Revascularization and Aggressive Drug Evaluation(COURAGE) trial nuclear substudy. Circulation 2008;117(10):1283–1291 100. Stergiopoulos K, Boden WE, Hartigan P, Mobius-Winkler S, Hambrecht R,HuebW, Hardison RM, Abbott JD, Brown DL. Percutaneous Coronary InterventionOutcomes in Patients With Stable Obstructive Coronary Artery Disease andMyocardial Ischemia:ACollaborative Meta-analysis of Contemporary RandomizedClinical Trials. JAMA Intern Med 2014;174(2):232–240 101. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F,Callister TQ, Chang HJ, Cheng V, Chinnaiyan K, Chow BJ, Delago A,Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines T,Berman DS. Age- and sex-related differences in all-cause mortality risk based oncoronary computed tomography angiography findings results from the InternationalMulticenterCONFIRM(CoronaryCTAngiography Evaluation for ClinicalOutcomes: An International Multicenter Registry) of 23,854 patients withoutknown coronary artery disease. J Am Coll Cardiol 2011;58(8):849–860 102. Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ, Lippolis NJ,Berman DS, Callister TQ. Prognostic value of multidetector coronary computedtomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol2007;50(12):1161–1170 103. Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 27th BethesdaConference: matching the intensity of risk factor management with the hazardfor coronary disease events. Task Force 5. Stratification of patients into high,medium and low risk subgroups for purposes of risk factor management. J AmColl Cardiol 1996;27(5):1007–1019 103a. Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M, Bellinger R, Martin A, Benton R, Delago A, Min JK. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol 2008;52:1724–1732. 104. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR Jr. Significance of periproceduralmyonecrosis on outcomes after percutaneous coronary intervention:an analysis of preintervention and postintervention troponin T levels in 5487patients. Circ Cardiovasc Interv 2008;1(1):10–19 105. Bangalore S, Pursnani S, Kumar S, Bagos PG. Percutaneous coronary interventionvs. optimal medical therapy for prevention of spontaneous myocardial infarction insubjects with stable ischemic heart disease. Circulation 2013;127(7):769–781 106. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, BrooksMM, Carrie D,Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kahler J, Kelsey SF,King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P,Sigwart U, Stables RH,OwensDK, Pocock SJ.Coronary artery bypass surgery comparedwith percutaneous coronary interventions for multivessel disease: a collaborativeanalysis of individual patient data from ten randomised trials. Lancet 2009;373(9670):1190–1197 107. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. The impact of revascularizationon mortality in patients with nonacute coronary artery disease. Am J Med2009;122(2):152–161 108. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T,Passamani E, Norris R et al. Effect of coronary artery bypass graft surgery on survival:overview of 10-year results from randomised trials by the Coronary ArteryBypass Graft Surgery Trialists Collaboration. Lancet 1994;344(8922):563–570 109. Long-term results of prospective randomised study of coronary artery bypasssurgery in stable angina pectoris. European Coronary Surgery Study Group Lancet 1982;2(8309):1173–1180 110. Eleven-year survival in the Veterans Administration randomized trial of coronarybypass surgery for stable angina. The Veterans Administration Coronary ArteryBypass Surgery Cooperative Study Group.NEngl J Med 1984;311(21):1333–1339 110a. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Eng J Med 2009;360:213–224. 111. Myocardial infarction and mortality in the coronary artery surgery study (CASS)randomized trial. N Engl J Med 1984;310(12):750–758 112. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G,Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC,O’Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH,Rouleau JL. Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 2011;364(17):1607–1616 113. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg D,Shurzinske L, McCormick LS. Aggressive lipid-lowering therapy compared withangioplasty in stable coronary artery disease. Atorvastatin vs. RevascularizationTreatment Investigators. N Engl J Med 1999;341(2):70–76 Íå íàøëè, ÷òî èñêàëè? Âîñïîëüçóéòåñü ïîèñêîì:
|